# Study of the Mechanisms of Action of Cladribine in Multiple Sclerosis

> **NCT04821596** · NA · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 77 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** biological collection

## Key facts

- **NCT ID:** NCT04821596
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-13
- **Primary completion:** 2021-12-14
- **Final completion:** 2021-12-14
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04821596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04821596, "Study of the Mechanisms of Action of Cladribine in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04821596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*